American Bio Medica Corp. (ABMC)
Stock Price:
$0.350 USD
-0.120 (-25.53%)
Updated Aug 10, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
12.58M |
| Revenue (ttm) |
3.46M |
| Net Income (ttm) |
-766,000 |
| Shares Out |
35.95M |
| EPS (ttm) |
-0.02 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 10, 2020 |
| Last Price |
$0.350 |
| Previous Close |
$0.470 |
| Change ($) |
-0.120 |
| Change (%) |
-25.53% |
| Day's Open |
0.460 |
| Day's Range |
0.305 - 0.489 |
| Day's Volume |
955,214 |
| 52-Week Range |
0.055 - 1.260 |
More Stats
| Market Cap |
12.58M |
| Enterprise Value |
13.55M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
35.95M |
| Float |
22.24M |
| EPS (basic) |
-0.02 |
| EPS (diluted) |
-0.02 |
| FCF / Share |
0.01 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
3.47% |
| Payout Ratio |
n/a |
| Shares Short |
5,863 |
| Short Ratio |
0.09 |
| Short % of Float |
n/a |
| Beta |
-0.70 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
28.80 |
| PS Ratio |
3.64 |
| PB Ratio |
n/a |
| Revenue |
3.46M |
| Operating Income |
-690,000 |
| Net Income |
-766,000 |
| Free Cash Flow |
437,000 |
| Net Cash |
-963,000 |
| Net Cash / Share |
-0.03 |
| Gross Margin |
34.21% |
| Operating Margin |
-19.94% |
| Profit Margin |
-22.10% |
| FCF Margin |
12.63% |
| ROA |
-16.78% |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
2.00
Current: $0.350
High
2.00
Target: 2.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 3.66 | 3.87 | 4.91 | 5.61 | 6.32 | 7.29 | 8.89 | 9.34 | 9.27 | 10.42 |
| Revenue Growth | -5.6% | -21.2% | -12.39% | -11.21% | -13.29% | -18.09% | -4.81% | 0.77% | -11.03% | - |
| Gross Profit | 1.18 | 1.29 | 2.00 | 2.49 | 2.86 | 3.06 | 3.57 | 3.34 | 3.88 | 4.11 |
| Operating Income | -0.59 | -0.76 | -0.31 | -0.26 | -0.01 | -0.22 | -1.13 | -0.93 | -0.15 | -0.53 |
| Net Income | -0.68 | -1.03 | -0.55 | -0.35 | -0.33 | -0.49 | -0.79 | -1.11 | -0.35 | -0.75 |
| Shares Outstanding | 32.53 | 30.12 | 29.21 | 27.46 | 25.68 | 23.34 | 22.27 | 21.83 | 21.74 | 21.74 |
| Earnings Per Share | -0.02 | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 | -0.05 | -0.02 | -0.03 |
| Operating Cash Flow | 0.06 | -0.22 | 0.18 | 0.24 | 0.23 | 0.10 | 0.01 | 0.24 | 0.45 | -0.05 |
| Capital Expenditures | - | - | -0.04 | - | -0.01 | -0.04 | -0.01 | -0.01 | -0.17 | -0.07 |
| Free Cash Flow | 0.06 | -0.22 | 0.14 | 0.24 | 0.22 | 0.06 | -0.01 | 0.23 | 0.28 | -0.12 |
| Cash & Equivalents | 0.00 | 0.11 | 0.04 | 0.16 | 0.16 | 0.35 | 0.65 | 0.09 | 0.09 | 0.04 |
| Total Debt | 1.57 | 1.54 | 1.32 | 1.47 | 1.81 | 2.17 | 2.34 | 1.85 | 2.00 | 2.23 |
| Net Cash / Debt | -1.57 | -1.42 | -1.29 | -1.31 | -1.65 | -1.82 | -1.69 | -1.76 | -1.91 | -2.19 |
| Assets | 2.08 | 2.48 | 2.89 | 3.37 | 3.69 | 4.08 | 4.97 | 4.78 | 5.64 | 6.02 |
| Liabilities | 2.87 | 2.62 | 2.27 | 2.35 | 2.73 | 3.11 | 3.63 | 3.42 | 3.27 | 3.36 |
| Book Value | -0.79 | -0.15 | 0.62 | 1.03 | 0.96 | 0.97 | 1.34 | 1.36 | 2.37 | 2.66 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
American Bio Medica Corp. |
| Country |
United States |
| Employees |
42 |
| CEO |
Melissa A. Waterhouse |
Stock Information
| Ticker Symbol |
ABMC |
| Stock Exchange |
US OTC |
| Unique Identifier |
OTCMKTS: ABMC |
| IPO Date |
December 24, 1997 |
Description
American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides bulk test strip contract manufacturing services to non-affiliated diagnostic companies. American Bio Medica Corporation serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.